Literature DB >> 19286580

Fibrinogen independently predicts the development of ischemic stroke in a Taiwanese population: CVDFACTS study.

Shao-Yuan Chuang1, Chyi-Huey Bai, Wei-Hung Chen, Li-Ming Lien, Wen-Harn Pan.   

Abstract

BACKGROUND AND
PURPOSE: Of few prospective studies that have focused on the relationship between fibrinogen and ischemic stroke (IS) in Asian populations, the findings were inconsistent with those conducted in Western countries. Therefore, we aimed to investigate the temporal relationship between fibrinogen levels (plus several related parameters) and IS in a community-based study in Taiwan.
METHODS: Baseline data from 3281 adults (>or=20 years of age) in the Cardiovascular Diseases Risk Factor Two-Township Study were linked to incidental IS status derived from insurance claims and death certificate records. Hazard ratios and 95% CIs of clotting factors (fibrinogen, factor VII, factor VIII, and antithrombin-III) for IS events were estimated using Cox proportional hazard models.
RESULTS: With 10.4 years (average) follow-up, 128 persons developed IS (3.75 per 1000 person-years). As expected, elevated blood pressure and diabetes were independent predictors of IS events. A dose-response relationship was found in univariate analysis between IS risk and tertiles of fibrinogen (hazard ratio, 3.73; 2.19 to 1.00), factor VII (hazard ratio, 1.86; 1.35 to 1.00), and factor VIII (2.97; 1.70 to 1.00), respectively, but not for antithrombin-III. After adjusting for confounding and known risk factors, fibrinogen independently predicted IS events. A 72% increase (hazard ratio, 1.72; 1.02 to 2.90) in IS risk was observed for individuals with fibrinogen >or=8.79 mumol/L compared with those <7.03 micromol/L.
CONCLUSIONS: In addition to hypertension and diabetes, fibrinogen independently predicted future IS risk. We suggest that fibrinogen may be considered in the risk assessment model for IS in the Taiwanese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286580     DOI: 10.1161/STROKEAHA.108.540492

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

1.  Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks.

Authors:  Hao-Min Cheng; Shao-Yuan Chuang; Shih-Hsien Sung; Wen-Chung Yu; Alan Pearson; Edward G Lakatta; Wen-Harn Pan; Chen-Huan Chen
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

Review 2.  Peripheral biomarkers of stroke: Focus on circulatory microRNAs.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2016-08-05

3.  Chronic stress, depressive symptoms, anger, hostility, and risk of stroke and transient ischemic attack in the multi-ethnic study of atherosclerosis.

Authors:  Susan A Everson-Rose; Nicholas S Roetker; Pamela L Lutsey; Kiarri N Kershaw; W T Longstreth; Ralph L Sacco; Ana V Diez Roux; Alvaro Alonso
Journal:  Stroke       Date:  2014-07-10       Impact factor: 7.914

Review 4.  The Novelty of the 2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Hao-Min Cheng; Chern-En Chiang; Chen-Huan Chen
Journal:  Pulse (Basel)       Date:  2015-04-29

5.  A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes.

Authors:  Chia-Min Chung; Tsung-Hsien Lin; Jaw-Wen Chen; Hsin-Bang Leu; Hsin-Chou Yang; Hung-Yun Ho; Chih-Tai Ting; Sheng-Hsiung Sheu; Wei-Chuan Tsai; Jyh-Hong Chen; Shing-Jong Lin; Yuan-Tsong Chen; Wen-Harn Pan
Journal:  Diabetes       Date:  2011-07-19       Impact factor: 9.461

6.  Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension.

Authors:  Hsin-Bang Leu; Chia-Min Chung; Shing-Jong Lin; Yuh-Shiun Jong; Wen-Harn Pan; Jaw-Wen Chen
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

7.  Associations between fibrinogen levels and the risk of cardiovascular disease and all-cause death: a cohort study from the Chin-Shan community in Taiwan.

Authors:  Cheng-Tzu Hsieh; Kuo-Liong Chien; Hsiu-Ching Hsu; Hung-Ju Lin; Ta-Chen Su; Ming-Fong Chen; Yuan-Teh Lee
Journal:  BMJ Open       Date:  2022-04-01       Impact factor: 2.692

8.  The role of hs-CRP, D-dimer and fibrinogen in differentiating etiological subtypes of ischemic stroke.

Authors:  Li-Bin Liu; Mu Li; Wen-Yan Zhuo; Yu-Sheng Zhang; An-Ding Xu
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

9.  A Mendelian randomization of γ' and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke.

Authors:  Jillian Maners; Dipender Gill; Nathan Pankratz; Michael A Laffan; Alisa S Wolberg; Moniek P M de Maat; Symen Ligthart; Weihong Tang; Cavin K Ward-Caviness; Myriam Fornage; Stephanie Debette; Martin Dichgans; Barbara McKnight; Eric Boerwinkle; Nicholas L Smith; Alanna C Morrison; Abbas Dehghan; Paul S de Vries
Journal:  Blood       Date:  2020-12-24       Impact factor: 22.113

Review 10.  Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium.

Authors:  Yu Chen; Wade K Copeland; Rajesh Vedanthan; Eric Grant; Jung Eun Lee; Dongfeng Gu; Prakash C Gupta; Kunnambath Ramadas; Manami Inoue; Shoichiro Tsugane; Akiko Tamakoshi; Yu-Tang Gao; Jian-Min Yuan; Xiao-Ou Shu; Kotaro Ozasa; Ichiro Tsuji; Masako Kakizaki; Hideo Tanaka; Yoshikazu Nishino; Chien-Jen Chen; Renwei Wang; Keun-Young Yoo; Yoon-Ok Ahn; Habibul Ahsan; Wen-Harn Pan; Chung-Shiuan Chen; Mangesh S Pednekar; Catherine Sauvaget; Shizuka Sasazuki; Gong Yang; Woon-Puay Koh; Yong-Bing Xiang; Waka Ohishi; Takashi Watanabe; Yumi Sugawara; Keitaro Matsuo; San-Lin You; Sue K Park; Dong-Hyun Kim; Faruque Parvez; Shao-Yuan Chuang; Wenzhen Ge; Betsy Rolland; Dale McLerran; Rashmi Sinha; Mark Thornquist; Daehee Kang; Ziding Feng; Paolo Boffetta; Wei Zheng; Jiang He; John D Potter
Journal:  BMJ       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.